FDA approves new oral three-drug regimen for extensively drug-resistant TB

The treatment involves pretomanid tablets in combination with bedaquiline and linezolid, collectively referred to as the BPaL regimen, and has an …

India tops nations burdened by TB

Absence of new drugs and vaccines, funds shortage affecting treatment and control

Scientists identify new route to tackle TB

Researchers analysed the genome of Mycobacterium tuberculosis and identified three G-quadruplex motifs that could be used as drug targets

Tuberculosis control in India: towards universal access

Revised TB control programme needs to evolve an inclusive business model to engage the Indian private sector to ensure better quality of TB care

Centre agrees to provide restricted TB drug to a Bihar girl; expert advices caution

The Health Ministry promises to make bedaquiline available to 70 centres across India

Gains in tuberculosis control threatened by drug resistance

Drug resistant TB is now a transmitted diseases and requires commitment, especially in high-burden countries like India 

New estimate suggests a quarter of the world's population has latent tuberculosis

Eradicating TB won't happen unless the number of people who are latent carriers is tackled. A new estimate suggests it's a much bigger problem …

The new tuberculosis drug is effective, but unaffordable

The drug "delamanid" is not registered in countries with high tuberculosis rates, limiting its access

Scientists find new way to improve efficacy of TB treatment

The new add-on therapy consists of injecting ‘heat-killed’ bacteria into patients along with standard TB drugs

TB drugs stock-outs trigger protests

Paediatric drug buffer stocks to last one month; emergency drug procurement by July 15

Antibiotic resistance: South Africa has a success story in treating resistant TB

Antimicrobial resistance is a worry as in several other African countries  

Towards ending childhood tuberculosis

TB is a preventable and curable disease, yet it kills more than 200 children in India every day

WHO recommends faster and cheaper treatment for Multi-Drug Resistant TB

This is a critical step forward in tackling the MDR-TB public health crisis, says organisation

Diagnosing extra-pulmonary TB

TB that affects different parts of the body other than lungs—extra-pulmonary TB—like lymph nodes or bones, accounts for nearly 15 per …

HIV-associated tuberculosis on the rise: India TB Report

Pediatric and drug-resistant TB major concerns for India

Indian pharmacies not responsible for spreading drug resistant TB, finds research

However, they did contribute to delays in TB diagnosis, it concludes

International Tuberculosis Day: An old foe is back, says The Phantom Plague

‘Phantom Plague’ traces the history of tuberculosis from its origins to its global subsidence and the recent rise, especially in …

New treatment against drug-resistant TB successful

Multidrug-resistant TB is a serious public health challenge. It affects vulnerable communities such as migrant workers, refugees, prisoners and …

New cure raises hopes for MDR-TB patients

PaMZ regimen showed better results among HIV-infected patients

India leads list of nations where TB cases go unreported: WHO

Global Tuberculosis Report says 900,000 cases in India are either not diagnosed or not reported to health authorities

MDR-TB cases in India increase more than five-fold in two years

Minister says better surveillance and detection is the reason

Antibiotic resistance a big threat to TB treatment in India

TB programme grappling with lack of funds; weak enforcement of standards another problem

Medicine for drug-resistant TB added to government programme

The drug will be introduced in six tertiary care centers across India

Why India must keep investing in health innovations

Only by committing ourselves to funding health innovation in the long term will India be able to realise today’s most urgently-needed solutions

WHO roadmap to end TB in children focuses for 1st time on pregnant, post-partum women affected by disease

Maternal, pregnancy, birth & infant outcomes should be included in dedicated safety studies for all new TB drugs & vaccines: WHO